QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LBRX

QT61LB Pharmaceuticals Inc Common Stock
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
30.00
-0.05-0.17%
OverviewShort InterestFilings
LBRXQT61LB Pharmaceuticals Inc Common Stock·NASDAQ
OverviewShort InterestFilings
30.00-0.17%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand28.68M
Perf Week5.12%
Market Cap861.73MForward P/E-EPS next Y-4.39Insider Trans-Shs Float-Perf Month10.01%
Enterprise Value544.53MPEG2.34EPS next Q-0.84Inst Own-Short Float-Perf Quarter25.05%
Income-39812083.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y51.36%
Sales-P/B2.24EPS next Y-24.49%ROA-9.95%Short Interest-Perf YTD34.77%
Book/sh13.21P/C-EPS next 5Y-ROE-17.68%52W High-Perf Year-
Cash/sh12.76P/FCF-EPS past 3/5Y-ROIC-12.23%52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-13.94Sales past 3/5Y-Gross Margin0.00%Volatility3.92% 3.88%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)1.71Perf 10Y-
Dividend Ex-Date-Quick Ratio35.68Sales Y/Y TTM-Profit Margin0.00%RSI (14)56.60Recom2.00
Dividend Gr. 3/5Y-Current Ratio35.68EPS Q/Q-48.89%SMA205.56%Beta0.64Target Price39.50
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA501.80%Rel Volume2.29Prev Close30.05
Employees16LT Debt/Eq0.01EarningsAug 11SMA200-Avg Volume223.76KPrice30.00
IPO DateSep 11, 2025Option/ShortYes / YesEPS/Sales Surpr.10.67% -Net Debt/EBITDA8.12Volume513,122Change-0.17%
Analyst Ratings
DateActionAnalystRatingTarget
May-17-26ReiteratedRoth Capital$31 → $37
Apr-27-26InitiatedH.CBuy$45
Apr-10-26InitiatedCraig-Hallum$36
Mar-27-26ReiteratedStifel Nicolaus$35 → $40
Jan-09-26InitiatedRoth CapitalBuy$31
Dec-11-25ReiteratedStifel Nicolaus$27 → $35
Oct-06-25InitiatedLeerinkOutperform$34
Oct-06-25InitiatedStifelBuy$27
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other14144
Research and Development17518
Other Operating Expense-10-1
Operating Income-30-65-11
Interest Expense005
Unusual Expense
———
Non-Operating Income (Expense)-5-2-10
Net Income Before Taxes-25-63-6
Income Taxes
000
Consolidated Net Income-25-63-6
Net Income From Continuing Operations-25-63-6
Net Income-25-63-6
EPS (Recurring)-1.00-17.83-1.77
EPS (Basic, Before Extraordinaries)-1.00-17.83-1.77
EPS (Diluted)-1.00-17.83-1.77
EBITDA-25-63-1
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding2544
Market Capitalization557——
Operating Lease Expense
———
Insider Trading Volume
$38.45$35.81$33.17$30.53$27.89● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR